TickerFacts.

Brainstorm Cell Therapeutics Inc. (BCLI): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2024-11-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

11.03M
As of 2025-12-31
11.03M
As of 2026-06-30
150.09M2010-12-31: 95.83M2011-12-31: 126.44M2012-12-31: 150.09M2013-12-31: 11.75M2014-12-31: 15.28M2015-12-31: 18.64M2016-12-31: 18.69M2017-12-31: 18.98M2018-12-31: 20.76M2019-12-31: 23.17M2020-12-31: 35.16M2021-12-31: 36.40M2022-12-31: 36.69M2023-12-31: 4.03M2024-12-31: 6.14M2025-12-31: 11.03M11.03M
2010-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3111.03M+79.7%2026-03-31, Balance as of period end
2024-12-316.14Mn/c2026-03-31, Balance as of period end
2023-12-314.03Mn/c2025-03-31, Balance as of period end
2022-12-3136.69M+0.8%2024-04-01, Balance as of period end
2021-12-3136.40M+3.5%2023-03-30, Balance as of period end
2020-12-3135.16Mn/c2022-03-28, Balance as of period end
2019-12-3123.17M+11.6%2021-02-04, Balance as of period end
2018-12-3120.76M+9.4%2020-02-18, Balance as of period end
2017-12-3118.98M+1.5%2019-04-01, Balance as of period end
2016-12-3118.69M+0.2%2018-03-08, Balance as of period end
2015-12-3118.64M+22.0%2017-03-29, Balance as of period end
2014-12-3115.28M+30.0%2016-03-09, Balance as of period end
2013-12-3111.75M-92.2%2015-03-26, Balance as of period end
2012-12-31150.09M+18.7%2014-03-27, Balance as of period end
2011-12-31126.44M+31.9%2013-03-14, Balance as of period end
2010-12-3195.83Mn/a2012-03-15, Balance as of period end